John K Nia

Secukinumab is Superior to Ustekinumab in Clearing Skin in Patients with Moderate to Severe Plaque Psoriasis (16-Week CLARITY Results)

Jerry Bagel, John K Nia, Peter W. Hashim et al. · Dermatology and Therapy · 2018 · 74 citations · Full text

Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin‐homing and systemic T‐cell populations

Tali Czarnowicki, H. Y. He, Hue-Chi Wen et al. · Allergy · 2017 · 64 citations

Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata

Emma Guttman‐Yassky, John K Nia, Peter W. Hashim et al. · Archives of Dermatological Research · 2018 · 61 citations

Extensive Alopecia Areata, Secukinumab Treatment, Clinical Dermatology +3

A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata

Daniela Mikhaylov, Ana B. Pavel, Christopher J. Yao et al. · Archives of Dermatological Research · 2018 · 59 citations

Medicine, Moderate-to-severe Alopecia Areata, Dermatology +1

Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial

Peter W. Hashim, Margot Chima, Hee J. Kim et al. · Journal of the American Academy of Dermatology · 2019 · 56 citations

Medicine, Clinical Dermatology, Crisaborole 2 +6